STRUCTURE OF 2 MICROCYSTINS - REFINEMENT WITH NUCLEAR OVERHAUSER EFFECTS AND ENSEMBLE CALCULATIONS

被引:13
作者
MIERKE, DF
RUDOLPHBOHNER, S
MULLER, G
MORODER, L
机构
[1] MAX PLANCK INST BIOCHEM, D-82152 MARTINSRIED, GERMANY
[2] CLARK UNIV, GUSTAF H CARLSON SCH CHEM, WORCESTER, MA 01610 USA
[3] UNIV MASSACHUSETTS, MED CTR, DEPT PHARMACOL, WORCESTER, MA 01655 USA
[4] BAYER AG, MD, IM, FA, COMPUTAT CHEM, D-51368 LEVERKUSEN, GERMANY
关键词
D O I
10.1002/bip.360360613
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ensemble calculations employing restraints developed from H-1-nmr were used to examine the conformational states of the two microcystins LR and LY. Despite the fast ''flip-flop'' dynamics about the N-methyl-dehydroalanine residue and adjacent residues, the main conformational characteristics of the cyclic heptapeptides consist of a compact ring formed by five of the seven amino acid residues with expulsion of a dipeptide portion out of the plane and the unnatural C20 beta-amino acid (2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid pointing upward from the ring. This structure of microcyst in LR shows high degrees of similarity with the energy-minimized structure of nodularin, a cyclic pentapeptide of identical inhibitory potency against protein phosphatases 1 and 2A. Comparison of these structures with those of the less toxic LY variant and with the structurally unrelated okadaic acid, known as potent inhibitor of the protein phosphatases 1 and 2A, allowed us to propose a rational binding mode of th is structural diverse set of natural inhibitors. (C) 1995 John Wiley & Sons, Inc.
引用
收藏
页码:811 / 828
页数:18
相关论文
共 68 条
[61]   SPECIFIC BINDING OF OKADAIC ACID, A NEW TUMOR PROMOTER IN MOUSE SKIN [J].
SUGANUMA, M ;
SUTTAJIT, M ;
SUGURI, H ;
OJIKA, M ;
YAMADA, K ;
FUJIKI, H .
FEBS LETTERS, 1989, 250 (02) :615-618
[62]   OKADAIC ACID - AN ADDITIONAL NON-PHORBOL-12-TETRADECANOATE-13-ACETATE-TYPE TUMOR PROMOTER [J].
SUGANUMA, M ;
FUJIKI, H ;
SUGURI, H ;
YOSHIZAWA, S ;
HIROTA, M ;
NAKAYASU, M ;
OJIKA, M ;
WAKAMATSU, K ;
YAMADA, K ;
SUGIMURA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (06) :1768-1771
[63]   AN ALTERNATIVE COMPUTER-MODEL OF THE 3-DIMENSIONAL STRUCTURES OF MICROCYSTIN-LR AND NODULARIN RATIONALIZING THEIR INTERACTIONS WITH PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2A [J].
TAYLOR, C ;
QUINN, RJ ;
MCCULLOCH, R ;
NISHIWAKIMATSUSHIMA, R ;
FUJIKI, H .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (04) :299-302
[64]   TIME-DEPENDENT DISTANCE RESTRAINTS IN MOLECULAR-DYNAMICS SIMULATIONS [J].
TORDA, AE ;
SCHEEK, RM ;
VANGUNSTEREN, WF .
CHEMICAL PHYSICS LETTERS, 1989, 157 (04) :289-294
[65]   PEPTIDOMIMETICS DERIVED FROM NATURAL-PRODUCTS [J].
WILEY, RA ;
RICH, DH .
MEDICINAL RESEARCH REVIEWS, 1993, 13 (03) :327-384
[66]   SESAME - A LEAST-SQUARES APPROACH TO THE EVALUATION OF PROTEIN STRUCTURES COMPUTED FROM NMR DATA [J].
YANG, JX ;
HAVEL, TF .
JOURNAL OF BIOMOLECULAR NMR, 1993, 3 (03) :355-360
[67]  
YASUMOTO T, 1984, SEAFOOD TOXINS, P207
[68]   INHIBITION OF PROTEIN PHOSPHATASES BY MICROCYSTIS AND NODULARIN ASSOCIATED WITH HEPATOTOXICITY [J].
YOSHIZAWA, S ;
MATSUSHIMA, R ;
WATANABE, MF ;
HARADA, K ;
ICHIHARA, A ;
CARMICHAEL, WW ;
FUJIKI, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (06) :609-614